Mecure Industries Limited, a leading human pharmaceuticals, and nutraceuticals manufacturing company will list 4 billion ordinary shares (4,000,000,000) on Nigerian Exchange Limited (NGX) by introduction at N2.96 per share.
This is another major listing for NGX in the pharmaceuticals industry as the company will add N11.84bn to the market capitalisation of the Exchange upon its addition to the Main Board. For more than a decade, Mecure Industries Plc has tapped into the power of new technology and innovation to advance the practice of medicine.
How FG will take 50m Nigerians out of poverty – Betta Edu
Despite huge investments, FG’s power plants remain dormant (I)
MeCure pioneered the development of novel products based on advances in technology and launched the pharmaceutical industry’s first tablet in a capsule formulation called Liquitab Floatcap.
With MeCure listing on the Exchange, NGX further reinforced itself as a platform of choice for corporates looking to raise capital.
